Advanced search
Publication Cover
Leukemia & Lymphoma Volume 59, 2018 - Issue 12
Submit an article Journal homepage
730
Views
26
CrossRef citations to date
0
Altmetric
Review

Immunological changes with kinase inhibitor therapy for chronic lymphocytic leukemia

Christopher PleyerHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USAORCID Iconhttp://orcid.org/0000-0002-9569-9605View further author information
ORCID Icon,
Adrian WiestnerHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USAView further author information
&
Clare SunHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-8498-4729View further author information
ORCID Icon
Pages 2792-2800 | Received 10 Jan 2018, Accepted 13 Mar 2018, Published online: 15 May 2018

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Othman Salim Akhtar, Adrienne Groman, Anil Singh, Paola Ghione, Ian Lund, Francisco J. Hernandez-Ilizaliturri & Pallawi Torka. (2022) Frequency and timing of other primary cancers in patients with chronic lymphocytic leukemia (CLL): a 17-year longitudinal study. Leukemia & Lymphoma 63:5, pages 1127-1136.
Read now
Csilla Markóth, Ibolya File, Róbert Szász, László Bidiga, József Balla & János Mátyus. (2021) Ibrutinib-induced acute kidney injury via interstitial nephritis. Renal Failure 43:1, pages 335-339.
Read now
Ganchimeg Ishdorj, Sara Beiggi, Zoann Nugent, Erin Streu, Versha Banerji, Dhali Dhaliwal, Salah M. Mahmud, Aaron J. Marshall, Spencer B. Gibson, Marni C. Wiseman & James B. Johnston. (2019) Risk factors for skin cancer and solid tumors in newly diagnosed patients with chronic lymphocytic leukemia and the impact of skin surveillance on survival. Leukemia & Lymphoma 60:13, pages 3204-3213.
Read now
Wilma Barcellini, Bruno Fattizzo & Anna Zaninoni. (2018) Current and emerging treatment options for autoimmune hemolytic anemia. Expert Review of Clinical Immunology 14:10, pages 857-872.
Read now

Articles from other publishers (22)

Yu. S. Torshina, N. B. Serebryanaya, T. V. Glazanova, M. A. Mikhalyova & S. V. Voloshin. (2023) Immunomodulating effects of antitumor drugs Bruton tyrosine kinase inhibitors and the possibility of their use in allergic and infectious diseases. Medical Immunology (Russia) 25:5, pages 1253-1258.
Crossref
Sebastian Faehling, Mariana Coelho, Alessia Floerchinger, Christof Schneider, Stephan Stilgenbauer, Peter Lichter, Martina Seiffert & Philipp M. Roessner. (2023) Simultaneous Inhibition of PI3Kgamma and PI3Kdelta Deteriorates T-cell Function With Implications for Chronic Lymphocytic Leukemia. HemaSphere 7:3, pages e840.
Crossref
Yanyan Liu, Yongping Song & Qingsong Yin. (2022) Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia. Frontiers in Immunology 13.
Crossref
Maria Stefania Infante, Ana Fernández‐Cruz, Lucia Núñez, Cecilia Carpio, Ana Jiménez‐Ubieto, Javier López‐Jiménez, Lourdes Vásquez, Raquel Del Campo, Samuel Romero, Carmen Alonso, Daniel Morillo, Margarita Prat, José Luis Plana, Paola Villafuerte, Gabriela Bastidas, Ana Bocanegra, Ángel Serna, Rodrigo De Nicolás, Juan Marquet, Carmen Mas‐Ochoa, Raúl Cordoba, Julio García‐Suárez, Alessandra Comai, Xavier Martín, Mariana Bastos‐Oreiro, Cristina Seri, Belén Navarro‐Matilla, Armando López‐Guillermo, Joaquín Martínez‐López, José Ángel Hernández‐Rivas, Isabel Ruiz‐Camps & Carlos Grande. (2021) Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study. Cancer Medicine 10:21, pages 7629-7640.
Crossref
Sining Zhu, Jaeyong Jung, Eton Victor, Johann Arceo, Samantha Gokhale & Ping Xie. (2021) Clinical Trials of the BTK Inhibitors Ibrutinib and Acalabrutinib in Human Diseases Beyond B Cell Malignancies. Frontiers in Oncology 11.
Crossref
Sining Zhu, Samantha Gokhale, Jaeyong Jung, Eris Spirollari, Jemmie Tsai, Johann Arceo, Ben Wang Wu, Eton Victor & Ping Xie. (2021) Multifaceted Immunomodulatory Effects of the BTK Inhibitors Ibrutinib and Acalabrutinib on Different Immune Cell Subsets – Beyond B Lymphocytes. Frontiers in Cell and Developmental Biology 9.
Crossref
Clare Sun & Adrian Wiestner. (2021) Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?. Hematology/Oncology Clinics of North America 35:4, pages 827-845.
Crossref
Candida Vitale, Elia Boccellato, Lorenzo Comba, Rebecca Jones, Francesca Perutelli, Valentina Griggio & Marta Coscia. (2021) Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia. Cancers 13:15, pages 3856.
Crossref
Clive S. Zent, Michael T. Brady, Carolyne Delage, Myla Strawderman, Nathan Laniewski, Phuong N. Contant, Preshetha Kanagaiah, Mark Y. Sangster, Paul M. Barr, Charles C. Chu, David J. Topham & Jonathan W. Friedberg. (2020) Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma. Leukemia 35:6, pages 1788-1791.
Crossref
Maria Cristina Puzzolo, Ilaria Del Giudice, Nadia Peragine, Paola Mariglia, Maria Stefania De Propris, Luca Vincenzo Cappelli, Livio Trentin, Gianluigi Reda, Antonio Cuneo, Stefano Molica, Alfonso Piciocchi, Valentina Arena, Francesca Romana Mauro, Anna Guarini & Robin Foà. (2021) TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia. Frontiers in Oncology 11.
Crossref
Francesca Romana Mauro, Diana Giannarelli, Clementina Maria Galluzzo, Candida Vitale, Andrea Visentin, Costantino Riemma, Serena Rosati, Marika Porrazzo, Sara Pepe, Marta Coscia, Livio Trentin, Massimo Gentile, Sara Raponi, Alessandra Micozzi, Giuseppe Gentile & Silvia Baroncelli. (2020) Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL). Leukemia 35:3, pages 737-746.
Crossref
Chaja F. Jacobs, Eric Eldering & Arnon P. Kater. (2021) Kinase inhibitors developed for treatment of hematologic malignancies: implications for immune modulation in COVID-19. Blood Advances 5:3, pages 913-925.
Crossref
Zuzana Mikulkova, Gayane Manukyan, Peter Turcsanyi, Milos Kudelka, Renata Urbanova, Jakub Savara, Eliska Ochodkova, Yvona Brychtova, Jan Molinsky, Martin Simkovic, David Starostka, Jan Novak, Ondrej Janca, Martin Dihel, Pavlina Ryznerova, Lekaa Mohammad, Tomas Papajik & Eva Kriegova. (2021) Deciphering the complex circulating immune cell microenvironment in chronic lymphocytic leukaemia using patient similarity networks. Scientific Reports 11:1.
Crossref
Michael J. Buege, Anita Kumar, Brianne N. Dixon, Laura A. Tang, Terry Pak, Jennifer Orozco, Tim J. Peterson & Kathryn T. Maples. (2020) Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents. Annals of Pharmacotherapy 54:9, pages 879-898.
Crossref
Philipp M. Roessner & Martina Seiffert. (2020) T-cells in chronic lymphocytic leukemia: Guardians or drivers of disease?. Leukemia 34:8, pages 2012-2024.
Crossref
Alberto Vogrig, Gian Luigi Gigli, Annacarmen Nilo, Maria Elena Pessa, Stefano Volpetti, Enrico Pegolo & Mariarosaria Valente. (2019) Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features. Journal of NeuroVirology 26:3, pages 437-441.
Crossref
Bhawana George, Sayan Mullick Chowdhury, Amber Hart, Anuvrat Sircar, Satish Kumar Singh, Uttam Kumar Nath, Mukesh Mamgain, Naveen Kumar Singhal, Lalit Sehgal & Neeraj Jain. (2020) Ibrutinib Resistance Mechanisms and Treatment Strategies for B-Cell Lymphomas. Cancers 12:5, pages 1328.
Crossref
Georgios Sogkas, Ignatius Ryan Adriawan, Natalia Dubrowinskaja, Faranaz Atschekzei & Reinhold Ernst Schmidt. 2020. 109 137 .
Clive S. Zent. (2019) Diagnosis and management of complications of chronic lymphocytic leukemia/small lymphocytic lymphoma. Acta Haematologica Polonica 50:3, pages 91-97.
Crossref
Iris de WeerdtTom HoflandRenate de BoerJohan A. Dobber, Julie Dubois, Denise van NieuwenhuizeMehrdad MobasherFransien de BoerMels HoogendoornGerjo A. VeldersMarjolein van der KliftEster B. M. Remmerswaal, Frederike J. BemelmanCarsten U. NiemannSabina KerstingMark-David Levin, Eric Eldering, Sanne H. Tonino & Arnon P. Kater. (2019) Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. Blood Advances 3:17, pages 2642-2652.
Crossref
Caroline Protin, Florence Abravanel, Laurent Alric, Suzanne Tavitian, Lucie Obéric, Jacques Izopet, Guillaume Martin-Blondel & Loic Ysebaert. (2019) Ribavirin for Chronic Hepatitis E Virus Infection in Ibrutinib-Exposed Patients. Open Forum Infectious Diseases 6:9.
Crossref
Giuseppe Curigliano & Rashmi R. Shah. (2019) Safety and Tolerability of Phosphatidylinositol-3-Kinase (PI3K) Inhibitors in Oncology. Drug Safety 42:2, pages 247-262.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.